Location History:
- Indianapolis, IN (US) (2010)
- Research Triangle Park, NC (US) (2010)
Company Filing History:
Years Active: 2010
Title: Innovations of Pingyun Y Chen in Pharmaceutical Patents
Introduction
Pingyun Y Chen is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of carvedilol salts and their applications in treating various cardiovascular conditions. With a total of 2 patents, his work has had a meaningful impact on medical treatments.
Latest Patents
Chen's latest patents include innovative formulations and methods related to carvedilol. One patent focuses on carvedilol salts and their corresponding compositions, which are used in the treatment of diseases such as hypertension, congestive heart failure, and angina. This invention introduces a novel crystalline form of carvedilol dihydrogen phosphate, enhancing the efficacy of the treatment. Another patent pertains to carvedilol hydrobromide, detailing its compositions and methods of use in similar medical conditions. This patent also presents a new crystalline form of carvedilol hydrobromide, further contributing to the therapeutic options available for patients.
Career Highlights
Throughout his career, Pingyun Y Chen has worked with reputable companies in the pharmaceutical industry. Notably, he has been associated with SmithKline Beecham Cork Limited and Sb Pharmco Puerto Rico Inc. His experience in these organizations has allowed him to refine his expertise in drug development and patenting.
Collaborations
Chen has collaborated with several professionals in his field, including Qunying Dai and Philip C Dell'Orco. These partnerships have facilitated the advancement of his research and the successful development of his patented inventions.
Conclusion
Pingyun Y Chen's contributions to pharmaceutical innovations, particularly in the area of carvedilol salts, demonstrate his commitment to improving medical treatments. His patents reflect a deep understanding of the complexities of drug formulation and the importance of effective therapies for cardiovascular diseases.